200 related articles for article (PubMed ID: 33213119)
1. Personalized treatment for differentiated thyroid cancer: current data and new perspectives.
Colombo C; Giancola N; Fugazzola L
Minerva Endocrinol (Torino); 2021 Mar; 46(1):62-89. PubMed ID: 33213119
[TBL] [Abstract][Full Text] [Related]
2. Summary and update on the management of differentiated thyroid cancer in 2023.
Raymond P; Klein M; Borson-Chazot F
Ann Endocrinol (Paris); 2024 Apr; 85(2):110-117. PubMed ID: 38316254
[TBL] [Abstract][Full Text] [Related]
3. Differentiated Thyroid Cancer-Treatment: State of the Art.
Schmidbauer B; Menhart K; Hellwig D; Grosse J
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629126
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response.
Campopiano MC; Ghirri A; Prete A; Lorusso L; Puleo L; Cappagli V; Agate L; Bottici V; Brogioni S; Gambale C; Minaldi E; Matrone A; Elisei R; Molinaro E
Front Endocrinol (Lausanne); 2023; 14():1133958. PubMed ID: 37152950
[TBL] [Abstract][Full Text] [Related]
5. Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
Juweid ME; Tulchinsky M; Mismar A; Momani M; Zayed AA; Al Hawari H; Albsoul N; Mottaghy FM
Int J Cancer; 2020 Nov; 147(9):2345-2354. PubMed ID: 32319676
[TBL] [Abstract][Full Text] [Related]
6. Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts.
Campennì A; Barbaro D; Guzzo M; Capoccetti F; Giovanella L
Endocrine; 2020 Nov; 70(2):280-291. PubMed ID: 32772339
[TBL] [Abstract][Full Text] [Related]
7. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
[TBL] [Abstract][Full Text] [Related]
8. [Current controversies in risk-adapted therapy in differentiated thyroid cancer: Is less (therapy) really more?].
Kurtaran A; Schmoll-Hauer B; Tugendsam C
Wien Med Wochenschr; 2020 Feb; 170(1-2):15-25. PubMed ID: 31797245
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine refractory differentiated thyroid cancer.
Jin Y; Van Nostrand D; Cheng L; Liu M; Chen L
Crit Rev Oncol Hematol; 2018 May; 125():111-120. PubMed ID: 29650270
[TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid cancer theranostics: radioiodine and beyond.
Choudhury PS; Gupta M
Br J Radiol; 2018 Nov; 91(1091):20180136. PubMed ID: 30260232
[TBL] [Abstract][Full Text] [Related]
11. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.
Lamartina L; Durante C; Lucisano G; Grani G; Bellantone R; Lombardi CP; Pontecorvi A; Arvat E; Felicetti F; Zatelli MC; Rossi R; Puxeddu E; Morelli S; Torlontano M; Crocetti U; Montesano T; Giubbini R; Orlandi F; Aimaretti G; Monzani F; Attard M; Francese C; Antonelli A; Limone P; Rossetto R; Fugazzola L; Meringolo D; Bruno R; Tumino S; Ceresini G; Centanni M; Monti S; Salvatore D; Spiazzi G; Mian C; Persani L; Barbaro D; Nicolucci A; Filetti S
Thyroid; 2017 Dec; 27(12):1490-1497. PubMed ID: 29020892
[TBL] [Abstract][Full Text] [Related]
12. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
13. [Indications and results of radioiodine treatment of differentiated thyroid cancer].
Riemann B
Chirurg; 2020 Dec; 91(12):1013-1016. PubMed ID: 32749499
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications.
Van Nostrand D
Thyroid; 2018 Sep; 28(9):1083-1093. PubMed ID: 30105931
[TBL] [Abstract][Full Text] [Related]
15. Differentiated thyroid cancer-personalized therapies to prevent overtreatment.
Luster M; Weber T; Verburg FA
Nat Rev Endocrinol; 2014 Sep; 10(9):563-74. PubMed ID: 24981455
[TBL] [Abstract][Full Text] [Related]
16. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
Haugen BR
Cancer; 2017 Feb; 123(3):372-381. PubMed ID: 27741354
[TBL] [Abstract][Full Text] [Related]
17. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
18. Surgical options for thyroid cancer and post-surgical management.
Doubleday A; Sippel RS
Expert Rev Endocrinol Metab; 2018 May; 13(3):137-148. PubMed ID: 30058897
[TBL] [Abstract][Full Text] [Related]
19. Emerging Therapies for Radioactive Iodine Refractory Thyroid Cancer.
Kirtane K; Roth MY
Curr Treat Options Oncol; 2020 Feb; 21(3):18. PubMed ID: 32048061
[TBL] [Abstract][Full Text] [Related]
20. European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.
Luster M; Aktolun C; Amendoeira I; Barczyński M; Bible KC; Duntas LH; Elisei R; Handkiewicz-Junak D; Hoffmann M; Jarząb B; Leenhardt L; Musholt TJ; Newbold K; Nixon IJ; Smit J; Sobrinho-Simões M; Sosa JA; Tuttle RM; Verburg FA; Wartofsky L; Führer D
Thyroid; 2019 Jan; 29(1):7-26. PubMed ID: 30484394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
